Patent · US Active

Neisseria meningitidis antigens and compositions

US9249196B2 · kind B2 · utility

29Cited by
30References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 26, 2012
Grant dateFeb 2, 2016
Priority date
Expiry dateJan 26, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.